Two Mechanistically Distinct Immune Evasion Proteins of Cowpox Virus Combine to Avoid Antiviral CD8 T Cells

Cell Host and Microbe

Volumn 6, Issue 5, 2009, Pages 422-432

  Byun, Minji ^a   Verweij, Marieke C ^b   Pickup, David J ^d   Wiertz, Emmanuel J H J ^b,c   Hansen, Ted H ^a   Yokoyama, Wayne M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

CELLBIO; MICROBIO; MOLIMMUNO

Indexed keywords

GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN CPXV12; PROTEIN CPXV203; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CD8+ T LYMPHOCYTE; CELL LINE; CELL SURFACE; CELLULAR IMMUNITY; CONTROLLED STUDY; COWPOX VIRUS; CYTOKINE PRODUCTION; CYTOTOXICITY; DNA VIRUS; DOWN REGULATION; ENDOPLASMIC RETICULUM; FEMALE; FLOW CYTOMETRY; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RETROVIRUS; THERMOSTABILITY; VERO CELL; VIRAL GENE DELIVERY SYSTEM; VIRUS GENOME; VIRUS INFECTION; VIRUS RECOMBINANT;

ANIMALS; CARRIER PROTEINS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; COWPOX; COWPOX VIRUS; DOWN-REGULATION; ENDOPLASMIC RETICULUM; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNE EVASION; MICE; MICE, INBRED C57BL; PROTEIN BINDING; VIRAL PROTEINS;

COWPOX VIRUS; DNA VIRUSES;

EID: 71749119357     PISSN: 19313128     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chom.2009.09.012     Document Type: Article

References (45)

1. Ahn K., Angulo A., Ghazal P., Peterson P.A., Yang Y., and Fruh K. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc. Natl. Acad. Sci. USA 93 (1996) 10990-10995
2. Ahn K., Meyer T.H., Uebel S., Sempe P., Djaballah H., Yang Y., Peterson P.A., Fruh K., and Tampe R. Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47. EMBO J. 15 (1996) 3247-3255
3. Ahn K., Gruhler A., Galocha B., Jones T.R., Wiertz E.J., Ploegh H.L., Peterson P.A., Yang Y., and Fruh K. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity 6 (1997) 613-621
4. Andersson M., Paabo S., Nilsson T., and Peterson P.A. Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance. Cell 43 (1985) 215-222
5. Boname J.M., de Lima B.D., Lehner P.J., and Stevenson P.G. Viral degradation of the MHC class I peptide loading complex. Immunity 20 (2004) 305-317
6. Bouvier M., and Wiley D.C. Importance of peptide amino and carboxyl termini to the stability of MHC class I molecules. Science 265 (1994) 398-402
7. Byun M., Wang X., Pak M., Hansen T.H., and Yokoyama W.M. Cowpox virus exploits the endoplasmic reticulum retention pathway to inhibit MHC class I transport to the cell surface. Cell Host Microbe 2 (2007) 306-315
8. Campbell J.A., Trossman D.S., Yokoyama W.M., and Carayannopoulos L.N. Zoonotic orthopoxviruses encode a high-affinity antagonist of NKG2D. J. Exp. Med. 204 (2007) 1311-1317
9. Chantrey J., Meyer H., Baxby D., Begon M., Bown K.J., Hazel S.M., Jones T., Montgomery W.I., and Bennett M. Cowpox: reservoir hosts and geographic range. Epidemiol. Infect. 122 (1999) 455-460
10. Coscoy L., and Ganem D. Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc. Natl. Acad. Sci. USA 97 (2000) 8051-8056
11. Dasgupta A., Hammarlund E., Slifka M.K., and Fruh K. Cowpox virus evades CTL recognition and inhibits the intracellular transport of MHC class I molecules. J. Immunol. 178 (2007) 1654-1661
12. Doom C.M., and Hill A.B. MHC class I immune evasion in MCMV infection. Med. Microbiol. Immunol. (Berl.) 197 (2008) 191-204
13. Fahnestock M.L., Tamir I., Narhi L., and Bjorkman P.J. Thermal stability comparison of purified empty and peptide-filled forms of a class I MHC molecule. Science 258 (1992) 1658-1662
14. Fruh K., Ahn K., Djaballah H., Sempe P., van Endert P.M., Tampe R., Peterson P.A., and Yang Y. A viral inhibitor of peptide transporters for antigen presentation. Nature 375 (1995) 415-418
15. Goldsmith K., Chen W., Johnson D.C., and Hendricks R.L. Infected cell protein (ICP)47 enhances herpes simplex virus neurovirulence by blocking the CD8+ T cell response. J. Exp. Med. 187 (1998) 341-348
16. Guerin J.L., Gelfi J., Boullier S., Delverdier M., Bellanger F.A., Bertagnoli S., Drexler I., Sutter G., and Messud-Petit F. Myxoma virus leukemia-associated protein is responsible for major histocompatibility complex class I and Fas-CD95 down-regulation and defines scrapins, a new group of surface cellular receptor abductor proteins. J. Virol. 76 (2002) 2912-2923
17. Guidotti L.G., and Chisari F.V. To kill or to cure: options in host defense against viral infection. Curr. Opin. Immunol. 8 (1996) 478-483
18. Hansen T.H., and Bouvier M. MHC class I antigen presentation: learning from viral evasion strategies. Nat. Rev. Immunol. 9 (2009) 503-513
19. Hengel H., Koopmann J.O., Flohr T., Muranyi W., Goulmy E., Hammerling G.J., Koszinowski U.H., and Momburg F. A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity 6 (1997) 623-632
20. Hill A., Jugovic P., York I., Russ G., Bennink J., Yewdell J., Ploegh H., and Johnson D. Herpes simplex virus turns off the TAP to evade host immunity. Nature 375 (1995) 411-415
21. Hislop A.D., Ressing M.E., van Leeuwen D., Pudney V.A., Horst D., Koppers-Lalic D., Croft N.P., Neefjes J.J., Rickinson A.B., and Wiertz E.J. A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates. J. Exp. Med. 204 (2007) 1863-1873
22. Ishido S., Wang C., Lee B.S., Cohen G.B., and Jung J.U. Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J. Virol. 74 (2000) 5300-5309
23. Jones T.R., Wiertz E.J., Sun L., Fish K.N., Nelson J.A., and Ploegh H.L. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc. Natl. Acad. Sci. USA 93 (1996) 11327-11333
24. Karupiah G., Buller R.M., Van Rooijen N., Duarte C.J., and Chen J. Different roles for CD4+ and CD8+ T lymphocytes and macrophage subsets in the control of a generalized virus infection. J. Virol. 70 (1996) 8301-8309
25. Koppers-Lalic D., Reits E.A., Ressing M.E., Lipinska A.D., Abele R., Koch J., Marcondes Rezende M., Admiraal P., van Leeuwen D., Bienkowska-Szewczyk K., et al. Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing. Proc. Natl. Acad. Sci. USA 102 (2005) 5144-5149
26. Koppers-Lalic D., Verweij M.C., Lipinska A.D., Wang Y., Quinten E., Reits E.A., Koch J., Loch S., Rezende M.M., Daus F., et al. Varicellovirus UL 49.5 proteins differentially affect the function of the transporter associated with antigen processing, TAP. PLoS Pathog. 4 (2008) e1000080 10.1371/journal.ppat.1000080
27. Lehner P.J., Karttunen J.T., Wilkinson G.W., and Cresswell P. The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. Proc. Natl. Acad. Sci. USA 94 (1997) 6904-6909
28. Liu X., Kremer M., and Broyles S.S. A natural vaccinia virus promoter with exceptional capacity to direct protein synthesis. J. Virol. Methods 122 (2004) 141-145
29. Liu H., Fu J., and Bouvier M. Allele- and locus-specific recognition of class I MHC molecules by the immunomodulatory E3-19K protein from adenovirus. J. Immunol. 178 (2007) 4567-4575
30. Lybarger L., Wang X., Harris M.R., Virgin IV H.W., and Hansen T.H. Virus subversion of the MHC class I peptide-loading complex. Immunity 18 (2003) 121-130
31. Machold R.P., Wiertz E.J., Jones T.R., and Ploegh H.L. The HCMV gene products US11 and US2 differ in their ability to attack allelic forms of murine major histocompatibility complex (MHC) class I heavy chains. J. Exp. Med. 185 (1997) 363-366
32. Peaper D.R., and Cresswell P. Regulation of MHC class I assembly and peptide binding. Annu. Rev. Cell Dev. Biol. 24 (2008) 343-368
33. Reusch U., Muranyi W., Lucin P., Burgert H.G., Hengel H., and Koszinowski U.H. A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation. EMBO J. 18 (1999) 1081-1091
34. Schumacher T.N., Heemels M.T., Neefjes J.J., Kast W.M., Melief C.J., and Ploegh H.L. Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro. Cell 62 (1990) 563-567
35. Seet B.T., Johnston J.B., Brunetti C.R., Barrett J.W., Everett H., Cameron C., Sypula J., Nazarian S.H., Lucas A., and McFadden G. Poxviruses and immune evasion. Annu. Rev. Immunol. 21 (2003) 377-423
36. Smith S.C., and Allen P.M. Myosin-induced acute myocarditis is a T cell-mediated disease. J. Immunol. 147 (1991) 2141-2147
37. Stevenson P.G., Efstathiou S., Doherty P.C., and Lehner P.J. Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses. Proc. Natl. Acad. Sci. USA 97 (2000) 8455-8460
38. Stevenson P.G., May J.S., Smith X.G., Marques S., Adler H., Koszinowski U.H., Simas J.P., and Efstathiou S. K3-mediated evasion of CD8(+) T cells aids amplification of a latent gamma-herpesvirus. Nat. Immunol. 3 (2002) 733-740
39. Wagner M., Gutermann A., Podlech J., Reddehase M.J., and Koszinowski U.H. Major histocompatibility complex class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus. J. Exp. Med. 196 (2002) 805-816
40. Wiertz E.J., Jones T.R., Sun L., Bogyo M., Geuze H.J., and Ploegh H.L. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84 (1996) 769-779
41. Wiertz E.J., Tortorella D., Bogyo M., Yu J., Mothes W., Jones T.R., Rapoport T.A., and Ploegh H.L. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature 384 (1996) 432-438
42. Williams A.P., Peh C.A., Purcell A.W., McCluskey J., and Elliott T. Optimization of the MHC class I peptide cargo is dependent on tapasin. Immunity 16 (2002) 509-520
43. York I.A., Roop C., Andrews D.W., Riddell S.R., Graham F.L., and Johnson D.C. A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. Cell 77 (1994) 525-535
44. Ziegler H., Thale R., Lucin P., Muranyi W., Flohr T., Hengel H., Farrell H., Rawlinson W., and Koszinowski U.H. A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. Immunity 6 (1997) 57-66
45. Zuniga M.C., Wang H., Barry M., and McFadden G. Endosomal/lysosomal retention and degradation of major histocompatibility complex class I molecules is induced by myxoma virus. Virology 261 (1999) 180-192